MedPath

The effect of Acupoint Injection on improving insulin sensitivity in PCOS patients of kidney deficiency and blood stasis: a randomized controlled trial

Not Applicable
Not yet recruiting
Conditions
polycystic ovary syndrome
Registration Number
ITMCTR2200005645
Lead Sponsor
Chongqing Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

? Meet the recommendations of the expert meeting of the European Society for human reproduction and embryo and American Society of reproductive medicine (ESHRE / ASRM) in Rotterdam in 2003;
? 18-40 years old;
? Having no intention of pregnancy, taking non-drug contraceptive measures (male using condom) after selection;
? Those who can follow up according to the experimental requirements

Exclusion Criteria

? Persons over 40 years old or under 18 years old;
? Long term or recent application of exogenous androgen; Or being treated with corticosteroids; Or receiving malignant tumor treatment; Or have a history of drug abuse and alcoholism in the past 2 years;
? Those who have used metformin or other insulin sensitizers in the past 1 month;
? Combined with other endocrine diseases: such as hyperprolactinemia, thyroid disease, androgen secreting tumor, Cushing's syndrome, congenital adrenal cortical hyperplasia, etc;
? Those with serious cardiovascular, blood, liver and kidney diseases and low immune function; ALT or AST is higher than the upper limit of normal reference value, and serum creatinine is higher than the upper limit of normal reference value;
? Patients who cannot take effective contraceptive measures during the experiment;
? Patients with other infertility diseases besides PCOS;
? Pregnant and lactating women;
? Patients with a history of mental illness or active mental illness

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.